Press Releases

Date Title and Summary Additional Formats
Toggle Summary Omnicell to Present at Upcoming Investor Conferences
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Sep. 1, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will present at the following upcoming investor conferences: 2020 Wells Fargo Virtual Healthcare...
View HTML
Toggle Summary Omnicell to Acquire Pharmaceutical Strategy Group’s Leading 340B Software-Enabled Service Business
Expands pharmacy supply chain capabilities for efficient, compliant management of 340B programs Accelerates Omnicell’s strategic transformation to support the vision of the fully Autonomous Pharmacy , building on the recent launch of Omnicell One Expected to be immediately accretive to non-GAAP...
View HTML
Toggle Summary Omnicell Reports Second Quarter 2020 Results
GAAP revenues of $199.6 million and net loss per diluted share of $0.10 Non-GAAP revenues $199.6 million and net income per diluted share of $0.37 Omnicell’s Response to Coronavirus (COVID-19) MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Jul. 28, 2020-- Omnicell, Inc....
View HTML
Toggle Summary Omnicell to Release Second Quarter 2020 Earnings Results on July 28, 2020
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Jul. 21, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Tuesday, July 28, 2020 , to discuss the Company’s Second Quarter...
View HTML
Toggle Summary Omnicell Reports First Quarter 2020 Results
GAAP and non-GAAP revenues of $229.7 million , up 13.4% year-over-year GAAP net income per diluted share of $0.26 , up 225.0% year-over-year Non-GAAP net income per diluted share of $0.66 , up 8.2% year-over-year Omnicell’s Response to Coronavirus (COVID-19) MOUNTAIN VIEW, Calif....
View HTML
Toggle Summary Omnicell to Release First Quarter 2020 Earnings Results on May 7, 2020
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Apr. 28, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, May 7, 2020 , to discuss the Company’s First Quarter 2020...
View HTML
Toggle Summary Omnicell Reports Fiscal Year and Fourth Quarter 2019 Results
Record annual GAAP and non-GAAP revenues of $897.0 million Record 2019 GAAP net income per diluted share of $1.43 Record 2019 non-GAAP net income per diluted share of $2.81 Record ending product backlog of $588 million MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Feb. 6, 2020-- Omnicell, Inc....
View HTML
Toggle Summary Omnicell to Release Fourth Quarter 2019 Earnings Results on February 6, 2020
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Jan. 30, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, February 6, 2020 , to discuss the Company’s Fourth Quarter...
View HTML
Toggle Summary Omnicell to Present at the 38th Annual J.P. Morgan Healthcare Conference
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Dec. 18, 2019-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that Randall Lipps , founder, chairman, president and CEO, and Peter Kuipers ,...
View HTML
Toggle Summary Omnicell to Present Strategic Priorities and Long-Term Financial Targets at Annual Innovation Day for Investors and Analysts
Company Focused on Advancing Capabilities in Automation, Intelligence and Services to Create Zero-Error, Fully Automated Medication Management Infrastructure MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Dec. 10, 2019-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions...
View HTML